Glen Wakeman helps others catch a vision for success

Everyone likes the idea of being an entrepreneur. The idea of “being your own boss” and only being limited by your imagination is one of the vital threads woven into the fabric of the American Dream. This idea, or dream, however, often turns into a nightmare if you don’t first have a solid plan and seek out much advice. Glen Wakeman is streamlining that process for ambitious entrepreneurs through the company he co-founded and serves as CEO, Launchpad Holdings, LLC.

Glen Wakeman uses his extensive experience gained at companies such as GE Capital, and as the founder of Nova Four, to encourage entrepreneurs with a good idea to broaden that idea into a full-fledged business plan. When asked about what prompted him to found Launchpad Holdings, he said, “People don’t always understand, an idea is not a plan itself. So we decided to make plan building easier and more intuitive by designing a simpler software platform.” While not everything can be planned for, of course, Glen’s real-world experience helps ensure that when using the software from Launchpad Holdings, you’re much less likely to forget important details that could have catastrophic consequences further down the line. Read more about Glen Wakeman at Affiliate Dork.

Glen is, by no means, a hands-off CEO. He is constantly gaining experience, aiding C-level executives at various companies, and currently counseling startups Dreamfunded and Sitter Bees. In addition, he cites “curiosity” as his most productive trait. He says, “I want to know why things are like they are, so I can better know how to change them.” These experiences are shaped and molded by his proven methodology, focusing on the five key performance areas of: execution, governance, human capital, leadership and risk management. All of this knowledge gained is then built into the Launchpad software to make it even more effective for the entrepreneurs who depend on it.

Glen stays humble, thinking back on what he considers his worst job, cleaning toilets at an automobile parts factory. In his humility, though, he says that job taught him, “that there is dignity in all types of labor, and I never again took any opportunity for granted.” A lesson for Glen Wakeman then, and one being learned by the many entrepreneurs benefiting from his software now.

Read: http://analystoffinance.com/2017/12/glen-wakeman/

Mikhail Blagosklonny Fights For Affordable Cancer Cures

Cancer is one of the leading causes of death in the United States today. When one receives a cancer diagnosis pain and expense can become nearly as devastating as the disease. Mikhail Blagosklonny is a cancer researcher whose hope is to find ways to treat cancer effectively while also ensuring that costs remain law.

Cancer treatments can be so costly that they are considered a luxury rather than necessary care. As a researcher and professor at the Oncology at Rosewell Park Cancer Institute, Mikhail Blagosklonny hopes to find ways that patients have access to good healthcare regardless of their financial status. The risk of developing a cancer increases as an individual ages and this particular link is an area of interest for Blagosklonny.

In addition to making care more affordable, Blagosklonny hopes to increase human longevity. Current cancer treatments are hard on the human body and can even inhibit an individual’s ability to recover once he or she is in remission. Aging people already have more difficulty when recovering from minor ailments than their younger counterparts. Recovery from radiation and surgery can significantly impact an elderly person’s quality of life. It is Blagosklonny’s hope that scientists can find ways to remove cancerous cells while protecting normal cells so that an individual’s ability to recover is enhanced.

One particular drug that Blagosklonny advocates using in cancer treatment is Rapamycin. The drug is also known as Sirolimus and has been historically used as an anti-fungal medicine. Through research and use it was discovered that the drug has antiproliferative and immunosuppressive effects thus making it useful for a variety of treatments. For cancer treatment in particular, Rapamycin promotes tumor regression and enhances the body’s immune response to cancerous cells. Therefore it can be an excellent supplement to other cancer eliminating therapies.

While Rapamycin is clearly an excellent drug for the treatment of cancer it also can be used to treat benign tumor growth. Tuberous Sclerosis Complex is a condition that causes benign tumors throughout the body. Studies have shown that Rapamycin suppresses the growth of these tumors. Because of its immunosuppressive properties Rapamycin has been used to prevent organ rejection in people who have had transplants. As a result, Rapamycin is an excellent drug for treating cancers and benign tumors in people who have received organ transplants.

In addition to its effectiveness in treating cancer, Rapamycin may be able to increase longevity in humans. This is a particular area of interest for Blagosklonny and in his research he has shown that when used in mice, Rapamycin can help fight tuberculosis. There is additional potential that the drug may be able to treat Alzheimer’s, Muscular Dystrophy, and Systemic Lupus Erythematosus. Mikhail Blagosklonny has contributed a great deal to the scientific community with his research on cancer and longevity. His work has attracted the attention of the medical and non-medical communities alike and will be an important step forward in the fight against cancer.

 

The Benefits of the Sentient AI for Online Stores

When you visit a website, you can be extra sure that there are mechanisms to help you navigate through the site, and that is especially true for online commerce.

 

Online stores like Amazon have many ways to help the customer travel from one section of the website to another with the help of an AI that gives recommendations based on what is searched the most. Google utilizes the same mechanism, and so does YouTube. And Fabletics, and all online stores in the world that have achieved an excellent reputation among customers. Nowadays, online stores cannot rely on their well-designed layout to guide clients through the different sections: An AI created for the recommendation part of the website does a much better job than relying on humans to do the work.

 

This is where the Sentient AI technology comes in. Every e-commerce needs it.

 

In the e-commerce world, the Sentient AI is agreed to be one of the best options in the world as a whole for the recommendation part of online shops and stores. It has some of the best and most well-developed features of any “recommendator” out there, and Sentient AI is continually being updated to pack more functionalities and increase the potential to give feedback for visitors and customers. When it comes to e-commerce, Sentient AI is recommended by many of the most significant companies in the market.

 

The Sentient AI does search engine optimization very well. While visitors of the website add items to their shopping carts, the Sentient AI has the ability of showing, in seconds, the most relevant products based on these items. That allows for online stores to sell items that they would otherwise not be selling without the help of this technology.

 

Besides the SEO work, it also does recommendation in many ways possible, depending on the customization of the creators and developers of the website. The Sentient AI is customizable, there are many functionalities that you can turn on and off, and that adapts exactly to your needs for the technology. Not every e-commerce needs every functionality of the software, but the core recommendation is very necessary.

 

With Sentient AI, you can create a website without needing to worry about how you are going to develop a system to transport visitors from one product to the other. The recommendations of the Sentient AI are very simple to implement and use, and you don’t need an entire team taking care of the recommendation phase.

Avaaz is Advancing True Activist Movements

Global activism has long been a tried and true method of working to affect change across the planet in a myriad of causes which includes items such as human rights, animal rights, and climate change. So, the next logical step was to take these petitions and pleas for change to the internet in the form of an online activist network of which Avaaz is probably one of the most well-known and successful of the entries. It is a US-based civic organization with its early roots having been formed in 2007, and now the group which takes its name from the Persian word for “voice” or “song” boasts a platform with over 44 million members looking to make the world a better place one step at a time.

Ricken Patel is one of the co-founders and the current president, and he has helped shape the organization into one that is well respected by so many with related causes. For example, businesses such as the Huffington Post to the Guardian and People Magazine have all had positive things to say about the man who graduated first in his class at Oxford and then went on to pursue his master’s degree at Harvard.

One of the central tenets of the Avaaz civic organization is that they have transformed into a place where no donations from organizations or foundations are accepted, with the individual donor becoming the key component in all of the causes. Donations of more than $5,000 are also not accepted so that the burden is outstretched across a more voluminous group of people. Some of the most heralded causes to be supported by Avaaz are things like the Paris Climate Accord which was a great victory in fighting climate change through the end of fossil fuels and ocean conservation efforts in collaboration with key countries such as Palau. The efforts should only gain further momentum as more and more people become aware of the Avaaz platform and start to leverage it for change in their own locales while also supporting more broader efforts all around the globe.

 

Tempus Continues to Grow, Gaining $70 Million in Series C Funding

It was recently announced that innovative medical company Tempus has raised more than $70 million in funds. The funds came from two core investors in the series C round, New Enterprise Associates and Investors Revolution Growth. Overall, Tempus has raised more than $130 million in three separate rounds of funding. This has all been raised since the company started in just 2015, launching it from a small medical startup to a top game changer in the field of cancer diagnostics. According to a recent article in Forbes Magazine, this brings the total valuation of Tempus to about $700 million dollars.

Tempus was co-founded by Eric Lefkofsky, who is a serial entrepreneur that also founded Groupon. He currently serves as Tempus’s Chief Executive Officer. Tempus is a rapidly growing technology company that focuses on data driven cancer care. It is a complete informational system that is seeking to become the world’s largest data base of cancer information.

Lefkofsky founded Tempus after realizing that although there is a mass of data about cancer treatment and research methods there was no singular operating system that allowed doctors to access that data. Most of the information was contained in physicians notes that were filed away at individual hospitals rather than a central system. Tempus is seeking to change all that by centralizing the data and information.

Lefkofsky’s vision is to utilize the power of technology to complete this process. This is incredibly beneficial for the cancer patients who can benefit from this information being in the hands of their oncologists and the team. Cancer care becomes completely personal with access to this multitude of information. Research gained from one patient can be accessed by an oncologist on the other side of the country in real time. Additionally, Tempus is scaling its Business to Business partnership. In 2016 they have partnered with the Cleveland Clinic, the Mayo Clinic and Duke University. Tempus continues to grow and scale, with more and more partnerships in the works for 2017 and beyond.